Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 3;123(17):2902-2909.
doi: 10.1016/j.bpj.2024.05.011. Epub 2024 May 15.

MHC-Fine: Fine-tuned AlphaFold for precise MHC-peptide complex prediction

Affiliations

MHC-Fine: Fine-tuned AlphaFold for precise MHC-peptide complex prediction

Ernest Glukhov et al. Biophys J. .

Abstract

The precise prediction of major histocompatibility complex (MHC)-peptide complex structures is pivotal for understanding cellular immune responses and advancing vaccine design. In this study, we enhanced AlphaFold's capabilities by fine-tuning it with a specialized dataset consisting of exclusively high-resolution class I MHC-peptide crystal structures. This tailored approach aimed to address the generalist nature of AlphaFold's original training, which, while broad-ranging, lacked the granularity necessary for the high-precision demands of class I MHC-peptide interaction prediction. A comparative analysis was conducted against the homology-modeling-based method Pandora as well as the AlphaFold multimer model. Our results demonstrate that our fine-tuned model outperforms others in terms of root-mean-square deviation (median value for Cα atoms for peptides is 0.66 Å) and also provides enhanced predicted local distance difference test scores, offering a more reliable assessment of the predicted structures. These advances have substantial implications for computational immunology, potentially accelerating the development of novel therapeutics and vaccines by providing a more precise computational lens through which to view MHC-peptide interactions.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Figures

Figure 1
Figure 1
Comparative analysis of prediction accuracy for class I MHC-peptide complexes using RMSD calculated for Cα atoms of peptides: performance of AlphaFold, Pandora, and MHC-Fine.
Figure 2
Figure 2
Comparative visualization of class I MHC-peptide complex prediction accuracy, reporting MHC-peptide RMSD calculated for Cα atoms. True peptide structure is shown in red, Pandora model in orange, and MHC-Fine in blue. (a) PDB: 6vb3: high precision of MHC-Fine. MHC-peptide RMSD for Cα atoms is 0.25 Å for MHC-Fine and 1.44 Å for Pandora. (b) PDB: 7n2o: moderate accuracy for both models. MHC-peptide RMSD for Cα atoms is 1.23 Å for MHC-Fine and 1.19 Å for Pandora. (c) PDB: 7mj7: significant deviations in predictions for both models. MHC-peptide RMSD for Cα atoms is 3.73 Å for MHC-Fine and 4.30 Å for Pandora. To see this figure in color, go online.
Figure 3
Figure 3
Error distribution for plDDT values of peptide residues. The red distribution represents the original AlphaFold model with a standard deviation of 9.2, whereas the blue distribution highlights our MHC-Fine model, which achieves a reduced standard deviation of 4.6, indicating a more precise confidence in structural predictions for peptide residues.
Figure 4
Figure 4
MHC-Fine confidence prediction. Samples are grouped by mean plDDT values for peptide residues. The chart displays the distribution of MHC-peptide RMSD alongside the percentage of samples within each specific plDDT range.

Update of

References

    1. Neefjes J., Jongsma M.L.M., et al. Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 2011;11:823–836. - PubMed
    1. Deng L., Mariuzza R.A. Recognition of self-peptide–MHC complexes by autoimmune T-cell receptors. Trends Biochem. Sci. 2007;32:500–508. - PMC - PubMed
    1. Rosendahl Huber S., van Beek J., et al. van Baarle D. T cell responses to viral infections - opportunities for peptide vaccination. Front. Immunol. 2014;5 - PMC - PubMed
    1. Ott P.A., Hu Z., et al. Wu C.J. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217–221. - PMC - PubMed
    1. Robinson J., Barker D.J., et al. Marsh S.G.E. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020;48:D948–D955. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources